Vial blinding for clinical trial

In clinical trials, it is important to safely blind the test preparations so that the test subjects cannot distinguish between verum and placebo. This is the only way to obtain valid results on the efficacy of the drug being tested. In the case of transparent vessels such as vials, this poses particular challenges for a blinding solution, as their Content must be neutralised in terms of colour while remaining visible be.

Schreiner MediPharm has a Coloured foil label for vials which are filled with a liquid active ingredient. The special blinding solution consists of a Self-adhesive label with semi-transparent yellow colouring. This means that different liquids filled in vials can no longer be distinguished from one another. At the same time, the However, the label is transparent enough to recognise the fill level of the liquid it contains. The solution thus ensures efficient and flexible blinding of the test samples and helps to optimise the processes within the clinical trial.

The blinding label was designed by Schreiner MediPharm in collaboration with WuXi STA, a global company active in contract research, development and production. Among other things, the company offers clinical supply services for clinical trials and has been manufacturing investigational medicinal products since 2008. The blinding solution from Schreiner MediPharm and WuXi STA has been developed precisely for the vials - and complies with international regulations for clinical trials.

Source: Schreiner MediPharm